More evidence of the benefits of rational antimicrobial use in clinical practice

Infection Control and Hospital Epidemiology

Volumn 24, Issue 9, 2003, Pages 642-643

  Paterson, David L ^a   McCormack, Joseph G ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CEFTAZIDIME; CHLORHEXIDINE; CIPROFLOXACIN; GLYCOPEPTIDE; PIPERACILLIN PLUS TAZOBACTAM; PSEUDOMONIC ACID; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL FLORA; CLINICAL PRACTICE; DOSE CALCULATION; DRUG CHOICE; DRUG INDICATION; DRUG SAFETY; EDITORIAL; HUMAN; INFECTION CONTROL; INFECTION RISK; LONG TERM CARE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NOSE SMEAR; OSTEOMYELITIS; PHYSICIAN ATTITUDE; PNEUMONIA; PRESCRIPTION; RETROSPECTIVE STUDY; SCORING SYSTEM; TREATMENT OUTCOME; VENTILATOR;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; EVIDENCE-BASED MEDICINE; HUMANS; INFECTION CONTROL; PHYSICIAN'S PRACTICE PATTERNS; RISK FACTORS;

EID: 0141757399     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502273     Document Type: Editorial

References (9)

1. Bhalla A, Pultz NJ, Ray AJ, Hoyen CK, Eckstein EC, Donskey CJ. Antianaerobic antibiotic therapy promotes overgrowth of antibiotic-resistant, gram-negative bacilli and vancomycin-resistant enterococci in the stool of colonized patients. Infect Control Hosp Epidemiol 2003;24:644-649.
2. Bernard L, Vaudaux P, Vuagnat A, et al. Effect of vancomycin therapy for osteomyelitis on colonization by methicillin-resistant Staphylococcus aureus: lack of emergence of glycopeptide resistance. Infect Control Hosp Epidemiol 2003;24:650-654.
3. Lodise TP Jr, McKinnon PS, Rybak M. Prediction model to identify patients with Staphylococcus aureus bacteremia at risk for methicillin resistance. Infect Control Hosp Epidemiol 2003;24:655-661.
4. Cordero L, Ayers LW. Duration of empiric antibiotics for suspected early-onset sepsis in extremely low birth weight infants. Infect Control Hosp Epidemiol 2003;24:662-666.
5. Drlica K. The mutant selection window and antimicrobial resistance. J Antimicrob Chemother 2003;52:11-17.
6. Donskey CJ, Chowdhry TK, Hecker MT, et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med 2000;343:1925-1932.
7. Hecker MT, Aron DC, Patel NP, Lehmann MK, Donskey CJ. Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity. Arch Intern Med 2003;163:972-978.
8. Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit: a proposed solution for indiscriminate antibiotic precription. Am J Respir Crit Care Med 2000;162:505-511.
9. Muto CA, Jernigan JA, Ostrowksy BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003;24:362-386.